Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 399

1.

Cerebellar White Matter Disruption in Alzheimer's Disease Patients: A Diffusion Tensor Imaging Study.

Toniolo S, Serra L, Olivito G, Caltagirone C, Mercuri NB, Marra C, Cercignani M, Bozzali M.

J Alzheimers Dis. 2020 Feb 10. doi: 10.3233/JAD-191125. [Epub ahead of print]

PMID:
32065792
2.

Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.

Liguori C, Spanetta M, Izzi F, Franchini F, Nuccetelli M, Sancesario GM, Di Santo S, Bernardini S, Mercuri NB, Placidi F.

J Alzheimers Dis. 2020 Feb 10. doi: 10.3233/JAD-191124. [Epub ahead of print]

PMID:
32065791
3.

Pitolisant for treating narcolepsy comorbid with Parkinson's disease.

Liguori C, Placidi F, Izzi F, Mercuri NB, Stefani A, Pierantozzi M.

Sleep Med. 2020 Jan 28;69:86-87. doi: 10.1016/j.sleep.2020.01.020. [Epub ahead of print] No abstract available.

PMID:
32058232
4.

Dystonia: Sparse Synapses for D2 Receptors in Striatum of a DYT1 Knock-out Mouse Model.

D'Angelo V, Paldino E, Cardarelli S, Sorge R, Fusco FR, Biagioni S, Mercuri NB, Giorgi M, Sancesario G.

Int J Mol Sci. 2020 Feb 6;21(3). pii: E1073. doi: 10.3390/ijms21031073.

5.

Transient upregulation of translational efficiency in prodromal and early symptomatic Tg2576 mice contributes to Aβ pathology.

Borreca A, Valeri F, De Luca M, Ernst L, Russo A, Nobili A, Cordella A, Corsetti V, Amadoro G, Mercuri NB, D'Amelio M, Ammassari-Teule M.

Neurobiol Dis. 2020 Feb 4:104787. doi: 10.1016/j.nbd.2020.104787. [Epub ahead of print]

6.

On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity.

Ledonne A, Mercuri NB.

Int J Mol Sci. 2019 Dec 31;21(1). pii: E275. doi: 10.3390/ijms21010275. Review.

7.

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course.

Liguori C, Placidi F, Izzi F, Spanetta M, Mercuri NB, Di Pucchio A.

Alzheimers Res Ther. 2020 Jan 4;12(1):5. doi: 10.1186/s13195-019-0571-3.

8.

Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.

Kooij G, Derada Troletti C, Leuti A, Norris PC, Riley I, Albanese M, Ruggieri S, Libreros S, van der Pol SMA, van Het Hof B, Schell Y, Guerrera G, Buttari F, Mercuri NB, Centonze D, Gasperini C, Battistini L, de Vries HE, Serhan CN, Chiurchiù V.

Haematologica. 2019 Nov 28. pii: haematol.2019.219519. doi: 10.3324/haematol.2019.219519. [Epub ahead of print]

9.

Seasonality of restless legs syndrome: symptom variability in winter and summer times.

Liguori C, Holzknecht E, Placidi F, Izzi F, Mercuri NB, Högl B, Stefani A.

Sleep Med. 2020 Feb;66:10-14. doi: 10.1016/j.sleep.2019.07.026. Epub 2019 Aug 14.

PMID:
31770614
10.

Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study.

Liguori C, Costa C, Franchini F, Izzi F, Spanetta M, Cesarini EN, Di Santo S, Manfredi N, Farotti L, Romoli M, Lanari A, Salvadori N, Parnetti L, Calabresi P, Mercuri NB, Placidi F.

Epilepsy Behav. 2019 Dec;101(Pt A):106592. doi: 10.1016/j.yebeh.2019.106592. Epub 2019 Nov 11.

PMID:
31726425
11.

Systemic activation of Nrf2 pathway in Parkinson's disease.

Petrillo S, Schirinzi T, Di Lazzaro G, D'Amico J, Colona VL, Bertini E, Pierantozzi M, Mari L, Mercuri NB, Piemonte F, Pisani A.

Mov Disord. 2020 Jan;35(1):180-184. doi: 10.1002/mds.27878. Epub 2019 Nov 4.

PMID:
31682033
12.

The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses.

Napolitano F, De Rosa A, Russo R, Di Maio A, Garofalo M, Federici M, Migliarini S, Ledonne A, Rizzo FR, Avallone L, Nuzzo T, Biagini T, Pasqualetti M, Mercuri NB, Mazza T, Chambery A, Usiello A.

Sci Rep. 2019 Oct 25;9(1):15294. doi: 10.1038/s41598-019-51839-w.

13.

Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis.

Nicoletti CG, Landi D, Monteleone F, Mataluni G, Albanese M, Lauretti B, Rocchi C, Simonelli I, Boffa L, Buttari F, Mercuri NB, Centonze D, Marfia GA.

CNS Drugs. 2019 Nov;33(11):1133-1139. doi: 10.1007/s40263-019-00676-6.

PMID:
31650471
14.

Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording.

Della Rocca DG, Albanese M, Placidi F, Forle GB, Di Biase L, Ribatti V, Santini L, Izzi F, Cicchini L, Lovecchio M, Valsecchi S, Lavalle C, Natale A, Mercuri NB, Romigi A.

J Interv Card Electrophysiol. 2019 Dec;56(3):327-333. doi: 10.1007/s10840-019-00631-x. Epub 2019 Oct 23.

PMID:
31646429
15.

Hippocampal epileptogenesis in autoimmune encephalitis.

Romoli M, Krashia P, Sen A, Franciotta D, Gastaldi M, Nobili A, Mancini A, Nardi Cesarini E, Nigro P, Tambasco N, Mercuri NB, Parnetti L, Di Filippo M, D'Amelio M, Irani SR, Costa C, Calabresi P.

Ann Clin Transl Neurol. 2019 Nov;6(11):2261-2269. doi: 10.1002/acn3.50919. Epub 2019 Oct 15.

16.

Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease.

Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, Campanelli F, Natale G, Marino G, Calabrese V, Vedele F, Ghiglieri V, Picconi B, Di Lazzaro G, Schirinzi T, Sancesario G, Casadei N, Riess O, Bernardini S, Pisani A, Calabresi P, Viscomi MT, Serhan CN, Chiurchiù V, D'Amelio M, Mercuri NB.

Nat Commun. 2019 Oct 14;10(1):4725. doi: 10.1038/s41467-019-12538-2.

17.

Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease.

Di Lazzaro G, Ricci M, Al-Wardat M, Schirinzi T, Scalise S, Giannini F, Mercuri NB, Saggio G, Pisani A.

J Parkinsons Dis. 2020;10(1):113-122. doi: 10.3233/JPD-191758.

PMID:
31594252
18.

Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay.

Cariulo C, Martufi P, Verani M, Azzollini L, Bruni G, Weiss A, Deguire SM, Lashuel HA, Scaricamazza E, Sancesario GM, Schirinzi T, Mercuri NB, Sancesario G, Caricasole A, Petricca L.

Front Neurosci. 2019 Aug 22;13:889. doi: 10.3389/fnins.2019.00889. eCollection 2019.

19.

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease.

Krashia P, Cordella A, Nobili A, La Barbera L, Federici M, Leuti A, Campanelli F, Natale G, Marino G, Calabrese V, Vedele F, Ghiglieri V, Picconi B, Di Lazzaro G, Schirinzi T, Sancesario G, Casadei N, Riess O, Bernardini S, Pisani A, Calabresi P, Viscomi MT, Serhan CN, Chiurchiù V, D'Amelio M, Mercuri NB.

Nat Commun. 2019 Sep 2;10(1):3945. doi: 10.1038/s41467-019-11928-w. Erratum in: Nat Commun. 2019 Oct 14;10(1):4725.

20.

Rhythmic auditory stimulation in gait rehabilitation for traumatic brain and spinal cord injury.

Alashram AR, Annino G, Mercuri NB.

J Clin Neurosci. 2019 Nov;69:287-288. doi: 10.1016/j.jocn.2019.08.080. Epub 2019 Aug 23.

PMID:
31451378
21.

Attention Allocation to Financial Information: The Role of Color and Impulsivity Personality Trait.

Ceravolo MG, Cerroni R, Farina V, Fattobene L, Leonelli L, Mercuri NB, Raggetti G.

Front Neurosci. 2019 Aug 6;13:818. doi: 10.3389/fnins.2019.00818. eCollection 2019.

22.

Validation of the Italian version of the PSP Quality of Life questionnaire.

Picillo M, Cuoco S, Amboni M, Bonifacio FP, Bruschi F, Carotenuto I, De Micco R, De Rosa A, Del Prete E, Di Biasio F, Elifani F, Erro R, Fabbri M, Falla M, Franco G, Frosini D, Galantucci S, Lazzeri G, Magistrelli L, Malaguti MC, Milner AV, Minafra B, Olivola E, Pilotto A, Rascunà C, Rizzetti MC, Schirinzi T, Borroni B, Ceravolo R, Di Fonzo A, Marchese R, Mercuri NB, Modugno N, Nicoletti A, Padovani A, Santangelo G, Stefani A, Tessitore A, Volontè MA, Zangaglia R, Zappia M, Zibetti M, Barone P.

Neurol Sci. 2019 Dec;40(12):2587-2594. doi: 10.1007/s10072-019-04010-2. Epub 2019 Jul 26.

PMID:
31350659
23.

Modified age-dependent expression of NaV1.6 in an ALS model correlates with motor cortex excitability alterations.

Saba L, Viscomi MT, Martini A, Caioli S, Mercuri NB, Guatteo E, Zona C.

Neurobiol Dis. 2019 Oct;130:104532. doi: 10.1016/j.nbd.2019.104532. Epub 2019 Jul 11.

PMID:
31302244
24.

Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy.

Picillo M, Cuoco S, Amboni M, Bonifacio FP, Bruno A, Bruschi F, Cappiello A, De Micco R, De Rosa A, Di Biasio F, Elifani F, Erro R, Fabbri M, Falla M, Franco G, Frosini D, Galantucci S, Lazzeri G, Magistrelli L, Malaguti MC, Milner AV, Minafra B, Olivola E, Pilotto A, Rascunà C, Rizzetti MC, Schirinzi T, Borroni B, Ceravolo R, Di Fonzo A, Lopiano L, Marchese R, Mercuri NB, Modugno N, Nicoletti A, Padovani A, Santangelo G, Stefani A, Tessitore A, Volontè MA, Zangaglia R, Zappia M, Barone P.

Neurol Sci. 2019 Oct;40(10):2163-2169. doi: 10.1007/s10072-019-03944-x. Epub 2019 Jun 12.

PMID:
31190253
25.

The effect of postural deformities on back function and pain in patients with Parkinson's disease.

Alwardat M, Schirinzi T, Di Lazzaro G, Franco D, Sinibaldi Salimei P, Mercuri NB, Pisani A.

NeuroRehabilitation. 2019;44(3):419-424. doi: 10.3233/NRE-182637.

PMID:
31177242
26.

Dysbiosis of gut microbiota in a selected population of Parkinson's patients.

Pietrucci D, Cerroni R, Unida V, Farcomeni A, Pierantozzi M, Mercuri NB, Biocca S, Stefani A, Desideri A.

Parkinsonism Relat Disord. 2019 Aug;65:124-130. doi: 10.1016/j.parkreldis.2019.06.003. Epub 2019 Jun 3.

PMID:
31174953
27.

Evaluation of the psychometric properties of the Barthel Index in an Italian ischemic stroke population in the acute phase: a cross-sectional study.

Galeoto G, Formica MC, Mercuri NB, Santilli V, Berardi AC, Castiglia SF, Mollica R, Servadio A.

Funct Neurol. 2019 Jan-Mar;34(1):29-34.

PMID:
31172937
28.

Subclinical cochlear dysfunction in newly diagnosed relapsing-remitting multiple sclerosis.

Di Mauro R, Di Girolamo S, Ralli M, de Vincentiis M, Mercuri N, Albanese M.

Mult Scler Relat Disord. 2019 Aug;33:55-60. doi: 10.1016/j.msard.2019.05.020. Epub 2019 May 27.

PMID:
31154261
29.

Impact of Pharmacological Inhibition of Hydrogen Sulphide Production in the SOD1G93A-ALS Mouse Model.

Spalloni A, Greco V, Ciriminna G, Corasolla Carregari V, Marini F, Pieroni L, Mercuri NB, Urbani A, Longone P.

Int J Mol Sci. 2019 May 24;20(10). pii: E2550. doi: 10.3390/ijms20102550.

30.

Neurotensin receptors inhibit mGluR I responses in nigral dopaminergic neurons via a process that undergoes functional desensitization by G-protein coupled receptor kinases.

Martini A, Cordella A, Pisani A, Mercuri NB, Guatteo E.

Neuropharmacology. 2019 Sep 1;155:76-88. doi: 10.1016/j.neuropharm.2019.05.026. Epub 2019 May 22.

PMID:
31128122
31.

Cognitive rehabilitation post traumatic brain injury: A systematic review for emerging use of virtual reality technology.

Alashram AR, Annino G, Padua E, Romagnoli C, Mercuri NB.

J Clin Neurosci. 2019 Aug;66:209-219. doi: 10.1016/j.jocn.2019.04.026. Epub 2019 May 10.

PMID:
31085075
32.

L-DOPA-quinone Mediated Recovery from GIRK Channel Firing Inhibition in Dopaminergic Neurons.

Bizzarri BM, Botta L, Aversa D, Mercuri NB, Poli G, Barbieri A, Berretta N, Saladino R.

ACS Med Chem Lett. 2019 Jan 9;10(4):431-436. doi: 10.1021/acsmedchemlett.8b00477. eCollection 2019 Apr 11.

PMID:
30996775
33.

Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.

Del Bianco C, Placidi F, Liguori C, Mari L, Ulivi M, Ornello R, Pisani A, Mercuri NB, Izzi F.

Epilepsy Behav. 2019 May;94:178-182. doi: 10.1016/j.yebeh.2019.02.022. Epub 2019 Apr 6.

PMID:
30959275
34.

Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study.

Liguori C, Ruffini R, Olivola E, Chiaravalloti A, Izzi F, Stefani A, Pierantozzi M, Mercuri NB, Modugno N, Centonze D, Schillaci O, Placidi F.

Parkinsonism Relat Disord. 2019 Jul;64:97-105. doi: 10.1016/j.parkreldis.2019.03.017. Epub 2019 Mar 23.

PMID:
30930059
35.

Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.

Scaricamazza E, Colonna I, Sancesario GM, Assogna F, Orfei MD, Franchini F, Sancesario G, Mercuri NB, Liguori C.

Neurol Sci. 2019 Jul;40(7):1377-1382. doi: 10.1007/s10072-019-03840-4. Epub 2019 Mar 22.

PMID:
30903419
36.

Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence.

Schirinzi T, Martella G, Imbriani P, Di Lazzaro G, Franco D, Colona VL, Alwardat M, Sinibaldi Salimei P, Mercuri NB, Pierantozzi M, Pisani A.

Front Neurol. 2019 Feb 26;10:148. doi: 10.3389/fneur.2019.00148. eCollection 2019.

37.

Assessment of Motor Impairments in Early Untreated Parkinson's Disease Patients: The Wearable Electronics Impact.

Ricci M, Di Lazzaro G, Pisani A, Mercuri NB, Giannini F, Saggio G.

IEEE J Biomed Health Inform. 2020 Jan;24(1):120-130. doi: 10.1109/JBHI.2019.2903627. Epub 2019 Mar 7.

PMID:
30843855
38.

Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk?

Liguori C, Mercuri NB, Nuccetelli M, Izzi F, Cordella A, Bernardini S, Placidi F.

Sleep Med. 2019 Apr;56:171-176. doi: 10.1016/j.sleep.2019.01.003. Epub 2019 Jan 11.

PMID:
30799255
39.

Effect of segmental muscle vibration on upper extremity functional ability poststroke: A randomized controlled trial.

Annino G, Alashram AR, Alghwiri AA, Romagnoli C, Messina G, Tancredi V, Padua E, Mercuri NB.

Medicine (Baltimore). 2019 Feb;98(7):e14444. doi: 10.1097/MD.0000000000014444.

40.

Association between physical activity and dementia's risk factors in patients with Parkinson's disease.

Alwardat M, Schirinzi T, Di Lazzaro G, Sancesario GM, Franco D, Imbriani P, Sinibaldi Salimei P, Bernardini S, Mercuri NB, Pisani A.

J Neural Transm (Vienna). 2019 Mar;126(3):319-325. doi: 10.1007/s00702-019-01979-0. Epub 2019 Feb 12.

PMID:
30746564
41.

The influence of postural deformities on neck function and pain in patients with Parkinson's disease.

Alwardat M, Schirinzi T, Di Lazzaro G, Franco D, Imbriani P, Sinibaldi Salimei P, Mercuri NB, Pisani A.

NeuroRehabilitation. 2019;44(1):79-84. doi: 10.3233/NRE-182505.

PMID:
30741700
42.

Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.

Massa R, Greco G, Testi M, Rastelli E, Terracciano C, Frezza E, Garibaldi M, Marfia GA, Locatelli F, Mercuri NB, Pompeo E, Antonini G, Andreani M.

J Neurol. 2019 Apr;266(4):982-989. doi: 10.1007/s00415-019-09225-z. Epub 2019 Feb 11.

PMID:
30741378
43.

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.

Liguori C, Turner K, Izzi F, Assogna M, Canevini MP, Mercuri NB, Placidi F.

CNS Neurosci Ther. 2019 May;25(5):632-637. doi: 10.1111/cns.13098. Epub 2019 Jan 23.

44.

Treating TB human neuroectodermal cell line with retinoic acid induces the appearance of neuron-like voltage-gated ionic currents.

Santillo S, Martini A, Polverino A, Mercuri NB, Guatteo E, Sorrentino G.

Brain Res. 2019 May 15;1711:97-105. doi: 10.1016/j.brainres.2019.01.019. Epub 2019 Jan 17.

PMID:
30660613
45.

CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD.

Liguori C, Paoletti FP, Placidi F, Ruffini R, Sancesario GM, Eusebi P, Mercuri NB, Parnetti L.

Curr Neurol Neurosci Rep. 2019 Jan 14;19(2):3. doi: 10.1007/s11910-019-0918-y. Review.

PMID:
30637520
46.

Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease.

Liguori C, Mercuri NB, Albanese M, Olivola E, Stefani A, Pierantozzi M.

J Neurol. 2019 Mar;266(3):636-641. doi: 10.1007/s00415-018-09179-8. Epub 2019 Jan 3.

PMID:
30607535
47.

New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay!

Liguori C, Moresco M, Izzi F, Mercuri NB, Plazzi G, Placidi F.

Psychiatry Clin Neurosci. 2019 Apr;73(4):194-195. doi: 10.1111/pcn.12816. Epub 2019 Feb 2. No abstract available.

PMID:
30588717
48.

RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models.

Bonsi P, Ponterio G, Vanni V, Tassone A, Sciamanna G, Migliarini S, Martella G, Meringolo M, Dehay B, Doudnikoff E, Zachariou V, Goodchild RE, Mercuri NB, D'Amelio M, Pasqualetti M, Bezard E, Pisani A.

EMBO Mol Med. 2019 Jan;11(1). pii: e9283. doi: 10.15252/emmm.201809283.

49.

Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease.

Motta C, Di Lorenzo F, Ponzo V, Pellicciari MC, Bonnì S, Picazio S, Mercuri NB, Caltagirone C, Martorana A, Koch G.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1237-1242. doi: 10.1136/jnnp-2017-317879. Epub 2018 Jul 21.

PMID:
30464028
50.

Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study.

Alessandrini M, Liguori C, Viziano A, Izzi F, Capoccia D, Lanzillotta A, Placidi F, Mercuri NB, Micarelli A.

Sleep Breath. 2019 Jun;23(2):665-672. doi: 10.1007/s11325-018-1754-z. Epub 2018 Nov 19.

PMID:
30456739

Supplemental Content

Loading ...
Support Center